FDA Adverse Event Injury Summary report: N

MITROFLOW LXA

MDR report key: 7705313 · Received July 19, 2018

Report

Report Number
3004478276-2018-00247
Event Type
Injury
Date Received
July 19, 2018
Date of Event
April 11, 2018
Report Date
October 4, 2018
Manufacturer
LIVANOVA CANADA CORP.
Product Code
LWR
UDI-DI
00896208000108
PMA / PMN Number
P060038
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CY
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 0

THE MANUFACTURING AND MATERIAL RECORDS FOR THE MITROFLOW BIOPROSTHETIC PERICARDIAL HEART VALVE, MODEL # LXA23, S/N # (B)(4), AS THEY PERTAIN TO THE REPORTED EVENT, WERE RETRIEVED AND REVIEWED BY QUALITY ENGINEERING AT (B)(4). THE RESULTS CONFIRMED THAT THIS VALVE SATISFIED ALL MATERIAL, VISUAL, AND PERFORMANCE STANDARDS REQUIRED FOR A LXA23 MITROFLOW AORTIC PERICARDIAL HEART VALVE AT THE TIME OF MANUFACTURE AND RELEASE. ADDITIONAL INFORMATION RECEIVED IDENTIFIED NO FURTHER INFORMATION IS AVAILABLE. BECAUSE THE DEVICE IS NOT AVAILABLE FOR RETURN AND NO FURTHER INFORMATION IS AVAILABLE THE ROOT CAUSE OF THE EVENT CANNOT BE DETERMINED AT THIS TIME. IF FURTHER INFORMATION IS RECEIVED THE CASE WILL BE REASSESSED. FIELDS CHANGED.

Additional Manufacturer Narrative · 1

DEVICE DISPOSITION PRESENTLY UNKNOWN.

Description of Event or Problem · 1

ON (B)(6) 2014 A MITROFLOW LXA21 WAS IMPLANTED. ON (B)(6) 2018 THE DEVICE WAS EXPLANTED AND REPLACED WITH A CROWN CNA23 AORTIC HEART VALVE IMPLANT. NO FURTHER INFORMATION WAS RECEIVED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
547190 MITROFLOW LXA TISSUE HEART VALVE LWR LIVANOVA CANADA CORP. LXA21 00896208000108

Patients

Seq Age Sex Outcome Treatment
1 64 YR Required Intervention